Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mindset Pharma Inc (OP: MSSTF ) N/A UNCHANGED Last Price Updated: 3:55 PM EDT, Oct 24, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.5381 Today's Range N/A - N/A 52wk Range 0.2404 - 0.5590 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic September 18, 2023 Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic... Via Benzinga Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More September 05, 2023 Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Via Benzinga Performance More News Read More Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions August 31, 2023 Via Benzinga Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application July 18, 2023 Via Benzinga Reunion Neuroscience On The Brink Of Going Private With Final Court Approval July 17, 2023 Via Benzinga Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More July 04, 2023 Via Benzinga Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3 June 29, 2023 Via Benzinga UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression June 27, 2023 Via Benzinga Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More May 01, 2023 Via Benzinga This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection April 26, 2023 Via Benzinga New Clinical MDMA And Psilocybin Batches Head To Flourishing Psychedelics Market April 25, 2023 Via Benzinga Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More March 20, 2023 Via Benzinga Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court March 14, 2023 Via Benzinga Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More March 13, 2023 Via Benzinga Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla March 06, 2023 Via Benzinga Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded February 03, 2023 Via Benzinga Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More January 25, 2023 Via Benzinga Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News January 21, 2023 Via Benzinga Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More November 21, 2022 Via Benzinga These Two Psychedelics Companies Team Up In An Exclusive Sales Deal, Here Are The Details November 16, 2022 Via Benzinga Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement November 16, 2022 From PharmAla Biotech Via GlobeNewswire EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance November 07, 2022 Via Benzinga European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed October 11, 2022 Via Benzinga Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More October 07, 2022 Via Benzinga Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials October 07, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.